Classification
- Anatomical main groupCCardiovascular system
- Therapeutic subgroupC02
- Pharmacological subgroupC02C
- Chemical subgroupC02CA
- Chemical substanceC02CA01Prazosin
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 21 registrations
- Apo-Prazo1 MG · Tablet · Apotex INC
- Apo-Prazo2 MG · Tablet · Apotex INC
- Apo-Prazo5 MG · Tablet · Apotex INC
- Teva-Prazosin2 MG · Tablet · Teva Canada Limited
New Zealand
PHARMAC (NZ funding schedule) · 9 registrations
Show all 9
At a glance
- ATC code
- C02CA01
- ATC group
- Cardiovascular system
- Registers
- 6
- Historical lists
- 1
- Registrations
- 50
- With their own page
- 30
- Companies
- 18
All medicines with Prazosin
Human medicines from every register that match Prazosin by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
50 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Prazosin Hydrochloride | United States | 1MG BASE, 2MG BASE, 5MG BASE | capsule | Marketed | Purepac Pharm |
| Prazosin Mylan | New Zealand | Cap 5 mg | Funded | ||
| Prazosin Mylan | New Zealand | Cap 2 mg | Funded | ||
| Prazosin Mylan | New Zealand | Cap 1 mg | Funded | ||
| Teva-Prazosin | Canada | 5 MG | Tablet | Marketed | Teva Canada Limited |
| Teva-Prazosin | Canada | 2 MG | Tablet | Marketed | Teva Canada Limited |
| Teva-Prazosin | Canada | 1 MG | Tablet | Marketed | Teva Canada Limited |
| APO-Prazosin | New Zealand | Tab 1 mg | Funded | ||
| APO-Prazosin | New Zealand | Tab 5 mg | Funded | ||
| APO-Prazosin | New Zealand | Tab 2 mg | Funded | ||
| Minipress | United States | 1MG BASE, 2MG BASE, 5MG BASE | capsule | Marketed | Pfizer |
| Minipress XL | United States | 2.5MG, 5MG | tablet, extended release | Not marketed | Pfizer |
| Apo-Prazo | Canada | 2 MG | Tablet | Marketed | Apotex INC |
| Apo-Prazo | Canada | 5 MG | Tablet | Marketed | Apotex INC |
| Apo-Prazo | Canada | 1 MG | Tablet | Marketed | Apotex INC |
| APO-PRAZO TABLET 1 mg | Singapore | 1 mg | tablet | Authorised | Pharmaforte Singapore Pte LTD |
| APO-PRAZO TABLET 2 mg | Singapore | 2 mg | tablet | Authorised | Pharmaforte Singapore Pte LTD |
| APO-PRAZO TABLET 5 mg | Singapore | 5 mg | tablet | Authorised | Pharmaforte Singapore Pte LTD |
| MINIPRES 1 mg COMPRIMIDOS | Spain | 1,095 mg | comprimido | Marketed | Pfizer S.L. |
| MINIPRES 2 mg COMPRIMIDOS | Spain | 2,190 mg | comprimido | Marketed | Pfizer S.L. |
| MINIPRES 5 mg COMPRIMIDOS | Spain | 5,476 mg | comprimido | Marketed | Pfizer S.L. |
| ATODEL 1 TABLET 1 mg | Singapore | 1 mg | tablet | Authorised | Goldplus Universal Pte LTD |
| Minison Tablet 1MG | Singapore | 1mg | tablet | Authorised | Yung Shin Pharmaceutical (Singapore) Pte LTD |
| MinizideCombination | United States | 0.5MG; 1MG BASE, 0.5MG; 2MG BASE, 0.5MG; 5MG BASE | capsule | Not marketed | Pfizer |
| Minipress | Canada | 5 MG | Tablet | Not marketed | Aa Pharma INC |